0 XP   0   0   0

EVEREST ORGANICS LTD.
Buy, Hold or Sell?

Should you buy, hold or sell EVEREST ORGANICS LTD.?

I guess you are interested in EVEREST ORGANICS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse EVEREST ORGANICS LTD.

Let's start. I'm going to help you getting a better view of EVEREST ORGANICS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is EVEREST ORGANICS LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how EVEREST ORGANICS LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value EVEREST ORGANICS LTD.. The closing price on 2023-02-08 was INR102.05 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
EVEREST ORGANICS LTD. Daily Candlestick Chart
EVEREST ORGANICS LTD. Daily Candlestick Chart
Summary









1. Valuation of EVEREST ORGANICS LTD.




Current price per share

INR102.05

2. Growth of EVEREST ORGANICS LTD.




Is EVEREST ORGANICS LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$3.1m$3.1m0.000.0%

How much money is EVEREST ORGANICS LTD. making?

Current yearPrevious yearGrowGrow %
Making money$1.3m$908.5k$409.9k31.1%
Net Profit Margin0.0%4.8%--

How much money comes from the company's main activities?

3. Financial Health of EVEREST ORGANICS LTD.




Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry




  Industry Rankings (Drug Manufacturers-Specialty & Generic)  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of EVEREST ORGANICS LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit EVEREST ORGANICS LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare EVEREST ORGANICS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of 0.0% means that ₹0.00 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of EVEREST ORGANICS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY4.8%-4.8%
TTM-5Y1.6%-1.6%
5Y1.6%10Y1.6%-0.1%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.4%-0.4%
TTM-0.3%-0.3%
YOY4.8%0.2%+4.6%
5Y1.6%-0.7%+2.3%
10Y1.6%-0.1%+1.7%
1.1.2. Return on Assets

Shows how efficient EVEREST ORGANICS LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare EVEREST ORGANICS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • 10.2% Return on Assets means that EVEREST ORGANICS LTD. generated ₹0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of EVEREST ORGANICS LTD.:

  • The MRQ is 10.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 10.2%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ10.2%TTM10.2%0.0%
TTM10.2%YOY7.0%+3.2%
TTM10.2%5Y4.2%+6.0%
5Y4.2%10Y3.5%+0.7%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ10.2%0.1%+10.1%
TTM10.2%0.1%+10.1%
YOY7.0%-0.1%+7.1%
5Y4.2%-0.2%+4.4%
10Y3.5%0.1%+3.4%
1.1.3. Return on Equity

Shows how efficient EVEREST ORGANICS LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare EVEREST ORGANICS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • 41.9% Return on Equity means EVEREST ORGANICS LTD. generated ₹0.42 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of EVEREST ORGANICS LTD.:

  • The MRQ is 41.9%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 41.9%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ41.9%TTM41.9%0.0%
TTM41.9%YOY28.9%+13.0%
TTM41.9%5Y18.3%+23.7%
5Y18.3%10Y24.5%-6.2%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ41.9%0.6%+41.3%
TTM41.9%0.4%+41.5%
YOY28.9%0.4%+28.5%
5Y18.3%-0.3%+18.6%
10Y24.5%0.1%+24.4%

1.2. Operating Efficiency of EVEREST ORGANICS LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient EVEREST ORGANICS LTD. is operating .

  • Measures how much profit EVEREST ORGANICS LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare EVEREST ORGANICS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of EVEREST ORGANICS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY9.9%-9.9%
TTM-5Y4.3%-4.3%
5Y4.3%10Y4.8%-0.5%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.5%-2.5%
TTM-1.6%-1.6%
YOY9.9%2.7%+7.2%
5Y4.3%1.8%+2.5%
10Y4.8%0.8%+4.0%
1.2.2. Operating Ratio

Measures how efficient EVEREST ORGANICS LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are ₹0.00 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of EVEREST ORGANICS LTD.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY1.528-1.528
TTM-5Y1.277-1.277
5Y1.27710Y1.409-0.131
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.473-1.473
TTM-1.456-1.456
YOY1.5281.398+0.130
5Y1.2771.374-0.097
10Y1.4091.191+0.218

1.3. Liquidity of EVEREST ORGANICS LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if EVEREST ORGANICS LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 1.07 means the company has ₹1.07 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of EVEREST ORGANICS LTD.:

  • The MRQ is 1.069. The company is just able to pay all its short-term debts.
  • The TTM is 1.069. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.069TTM1.0690.000
TTM1.069YOY0.940+0.129
TTM1.0695Y0.896+0.173
5Y0.89610Y0.835+0.061
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0691.880-0.811
TTM1.0691.901-0.832
YOY0.9402.112-1.172
5Y0.8962.182-1.286
10Y0.8351.891-1.056
1.3.2. Quick Ratio

Measures if EVEREST ORGANICS LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare EVEREST ORGANICS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 0.61 means the company can pay off ₹0.61 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of EVEREST ORGANICS LTD.:

  • The MRQ is 0.612. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.612. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.612TTM0.6120.000
TTM0.612YOY0.608+0.005
TTM0.6125Y0.582+0.031
5Y0.58210Y0.543+0.039
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6120.733-0.121
TTM0.6120.796-0.184
YOY0.6080.808-0.200
5Y0.5820.834-0.252
10Y0.5430.821-0.278

1.4. Solvency of EVEREST ORGANICS LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of EVEREST ORGANICS LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare EVEREST ORGANICS LTD. to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.76 means that EVEREST ORGANICS LTD. assets are financed with 75.8% credit (debt) and the remaining percentage (100% - 75.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of EVEREST ORGANICS LTD.:

  • The MRQ is 0.758. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.758. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.758TTM0.7580.000
TTM0.758YOY0.7580.000
TTM0.7585Y0.810-0.052
5Y0.81010Y0.856-0.046
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7580.437+0.321
TTM0.7580.424+0.334
YOY0.7580.398+0.360
5Y0.8100.398+0.412
10Y0.8560.401+0.455
1.4.2. Debt to Equity Ratio

Measures if EVEREST ORGANICS LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare EVEREST ORGANICS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 313.0% means that company has ₹3.13 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of EVEREST ORGANICS LTD.:

  • The MRQ is 3.130. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.130. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.130TTM3.1300.000
TTM3.130YOY3.1300.000
TTM3.1305Y5.265-2.135
5Y5.26510Y8.625-3.360
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1300.652+2.478
TTM3.1300.675+2.455
YOY3.1300.623+2.507
5Y5.2650.684+4.581
10Y8.6250.697+7.928

2. Market Valuation of EVEREST ORGANICS LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings EVEREST ORGANICS LTD. generates.

  • Above 15 is considered overpriced but always compare EVEREST ORGANICS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of 6.97 means the investor is paying ₹6.97 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of EVEREST ORGANICS LTD.:

  • The EOD is 7.492. Very good. +2
  • The MRQ is 6.975. Very good. +2
  • The TTM is 6.975. Very good. +2
Trends
Current periodCompared to+/- 
EOD7.492MRQ6.975+0.518
MRQ6.975TTM6.9750.000
TTM6.975YOY17.793-10.818
TTM6.9755Y40.482-33.507
5Y40.48210Y26.292+14.189
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD7.492-0.124+7.616
MRQ6.975-0.437+7.412
TTM6.975-0.102+7.077
YOY17.79315.340+2.453
5Y40.4827.916+32.566
10Y26.2927.700+18.592
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of EVEREST ORGANICS LTD..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of EVEREST ORGANICS LTD.:

  • The MRQ is 4.806. Seems overpriced? -1
  • The TTM is 4.806. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ4.806TTM4.8060.000
TTM4.806YOY4.061+0.744
TTM4.8065Y143.301-138.495
5Y143.30110Y102.910+40.391
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8060.012+4.794
TTM4.8060.010+4.796
YOY4.0610.004+4.057
5Y143.3010.010+143.291
10Y102.9100.021+102.889

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of EVEREST ORGANICS LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 2.93 means the investor is paying ₹2.93 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of EVEREST ORGANICS LTD.:

  • The EOD is 3.143. Neutral. Compare to industry.
  • The MRQ is 2.926. Good. +1
  • The TTM is 2.926. Good. +1
Trends
Current periodCompared to+/- 
EOD3.143MRQ2.926+0.217
MRQ2.926TTM2.9260.000
TTM2.926YOY5.143-2.217
TTM2.9265Y3.902-0.977
5Y3.90210Y2.796+1.107
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD3.1431.415+1.728
MRQ2.9261.586+1.340
TTM2.9262.019+0.907
YOY5.1432.230+2.913
5Y3.9021.895+2.007
10Y2.7961.505+1.291
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of EVEREST ORGANICS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0%9.117-100%5.042-100%4.059-100%
Book Value Growth--1.0001.0000%1.390-28%1.454-31%1.502-33%
Book Value Per Share--32.46932.4690%32.4690%23.176+40%16.253+100%
Book Value Per Share Growth--1.0001.0000%1.390-28%1.454-31%1.502-33%
Current Ratio--1.0691.0690%0.940+14%0.896+19%0.835+28%
Debt To Asset Ratio--0.7580.7580%0.7580%0.810-6%0.856-11%
Debt To Equity Ratio--3.1303.1300%3.1300%5.265-41%8.625-64%
Dividend Per Share--1.2061.2060%1.2060%0.964+25%0.603+100%
Dividend Per Share Growth--1.0001.0000%1.0000%1.0000%1.0000%
Eps--13.62113.6210%9.386+45%5.413+152%3.959+244%
Eps Growth--1.4511.4510%4.381-67%2.940-51%2.478-41%
Free Cash Flow Per Share--3.1473.1470%2.218+42%1.922+64%1.775+77%
Free Cash Flow Per Share Growth--1.4191.4190%1.663-15%3.256-56%2.609-46%
Free Cash Flow To Equity Per Share---2.264-2.2640%-1.175-48%-0.541-76%-0.439-81%
Free Cash Flow To Equity Per Share Growth--0.0720.0720%-33.921+46970%-5.524+7733%-4.134+5812%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--70.912--------
Intrinsic Value_10Y_min--59.489--------
Intrinsic Value_1Y_max--4.010--------
Intrinsic Value_1Y_min--3.896--------
Intrinsic Value_3Y_max--14.407--------
Intrinsic Value_3Y_min--13.565--------
Intrinsic Value_5Y_max--27.650--------
Intrinsic Value_5Y_min--25.195--------
Net Profit Margin----0%0.048-100%0.016-100%0.016-100%
Operating Margin----0%0.099-100%0.043-100%0.048-100%
Operating Ratio----0%1.528-100%1.277-100%1.409-100%
Pb Ratio3.143+7%2.9262.9260%5.143-43%3.902-25%2.796+5%
Pe Ratio7.492+7%6.9756.9750%17.793-61%40.482-83%26.292-73%
Peg Ratio--4.8064.8060%4.061+18%143.301-97%102.910-95%
Price Per Share102.050+7%95.00095.0000%167.000-43%95.990-1%61.438+55%
Price To Total Gains Ratio84.654+7%78.80578.8050%16.179+387%39.668+99%25.481+209%
Profit Growth--1.4511.4510%4.381-67%2.940-51%2.478-41%
Quick Ratio--0.6120.6120%0.608+1%0.582+5%0.543+13%
Return On Assets--0.1020.1020%0.070+45%0.042+144%0.035+193%
Return On Equity--0.4190.4190%0.289+45%0.183+129%0.245+71%
Revenue Growth----0%1.388-100%0.891-100%1.047-100%
Total Gains Per Share--1.2061.2060%10.322-88%6.006-80%4.661-74%
Total Gains Per Share Growth--0.1170.1170%2.317-95%12.819-99%9.565-99%
Usd Book Value--3143044.7933143044.7930%3143044.7930%2243437.565+40%1573307.435+100%
Usd Book Value Change Per Share----0%0.110-100%0.061-100%0.049-100%
Usd Book Value Per Share--0.3930.3930%0.3930%0.280+40%0.197+100%
Usd Dividend Per Share--0.0150.0150%0.0150%0.012+25%0.007+100%
Usd Eps--0.1650.1650%0.114+45%0.065+152%0.048+244%
Usd Free Cash Flow----0%-0%-0%-0%
Usd Free Cash Flow Per Share--0.0380.0380%0.027+42%0.023+64%0.021+77%
Usd Free Cash Flow To Equity Per Share---0.027-0.0270%-0.014-48%-0.007-76%-0.005-81%
Usd Price Per Share1.235+7%1.1501.1500%2.021-43%1.161-1%0.743+55%
Usd Profit--1318499.2121318499.2120%908537.999+45%523968.369+152%383251.129+244%
Usd Revenue----0%18907425.745-100%11516624.503-100%10539975.172-100%
Usd Total Gains Per Share--0.0150.0150%0.125-88%0.073-80%0.056-74%
 EOD+2 -3MRQTTM+0 -0YOY+15 -185Y+23 -1710Y+22 -18

3.2. Fundamental Score

Let's check the fundamental score of EVEREST ORGANICS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-157.492
Price to Book Ratio (EOD)Between0-13.143
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.612
Current Ratio (MRQ)Greater than11.069
Debt to Asset Ratio (MRQ)Less than10.758
Debt to Equity Ratio (MRQ)Less than13.130
Return on Equity (MRQ)Greater than0.150.419
Return on Assets (MRQ)Greater than0.050.102
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of EVEREST ORGANICS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose98.100
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2020-03-31. Currency in INR. All numbers in thousands.

Summary
 As reported
Total Liabilities -
Total Stockholder Equity+ -
Total Assets = -

Assets

Total Assets-
Total Current Assets791,351
Long-term Assets791,351
Total Current Assets
Net Receivables 453,266
Inventory 294,244
Other Current Assets 23,828
Total Current Assets  (as reported)791,351
Total Current Assets  (calculated)771,338
+/- 20,012
Long-term Assets
Property Plant Equipment 401,669
Long-term Assets  (as reported)0
Long-term Assets  (calculated)401,669
+/- 401,669

Liabilities & Shareholders' Equity

Total Current Liabilities740,054
Long-term Liabilities-
Total Stockholder Equity-
Total Current Liabilities
Accounts payable 444,336
Other Current Liabilities 99,926
Total Current Liabilities  (as reported)740,054
Total Current Liabilities  (calculated)544,262
+/- 195,792
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Retained Earnings 224,728
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)224,728
+/- 224,728
Other
Net Tangible Assets 342,022



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312012-03-312011-03-31
> Total Assets 
408,190
520,295
666,708
758,697
860,384
942,875
1,072,778
0
01,072,778942,875860,384758,697666,708520,295408,190
   > Total Current Assets 
223,480
308,212
419,036
466,491
492,428
581,684
668,503
791,351
791,351668,503581,684492,428466,491419,036308,212223,480
       Cash And Cash Equivalents 
15,804
10,985
10,499
10,611
5,920
12,697
19,616
0
019,61612,6975,92010,61110,49910,98515,804
       Net Receivables 
129,156
196,779
301,454
337,456
316,881
394,959
432,231
453,266
453,266432,231394,959316,881337,456301,454196,779129,156
       Inventory 
77,794
99,733
84,737
94,151
153,328
158,694
195,410
294,244
294,244195,410158,694153,32894,15184,73799,73377,794
       Other Current Assets 
727
715
22,347
24,274
16,299
15,334
21,246
23,828
23,82821,24615,33416,29924,27422,347715727
   > Long-term Assets 00000000
       Property Plant Equipment 
178,237
206,634
242,084
284,433
335,567
343,429
387,092
401,669
401,669387,092343,429335,567284,433242,084206,634178,237
       Long Term Investments 
845
845
845
845
845
845
845
0
0845845845845845845845
> Total Liabilities 
385,948
487,456
608,625
698,809
699,565
756,053
813,022
0
0813,022756,053699,565698,809608,625487,456385,948
   > Total Current Liabilities 
344,790
436,089
495,772
560,498
633,735
674,199
711,028
740,054
740,054711,028674,199633,735560,498495,772436,089344,790
       Short-term Debt 
182,663
183,541
19,620
17,363
21,375
26,716
21,621
0
021,62126,71621,37517,36319,620183,541182,663
       Short Long Term Debt 
182,663
183,541
19,620
17,363
21,375
26,716
21,621
0
021,62126,71621,37517,36319,620183,541182,663
       Accounts payable 
127,309
182,595
290,002
313,533
373,003
389,254
382,508
444,336
444,336382,508389,254373,003313,533290,002182,595127,309
       Other Current Liabilities 
52,627
89,715
31,180
52,655
70,949
75,231
97,764
99,926
99,92697,76475,23170,94952,65531,18089,71552,627
   > Long-term Liabilities 00000000
> Total Stockholder Equity
22,242
32,839
58,083
59,887
160,820
186,822
259,756
0
0259,756186,822160,82059,88758,08332,83922,242
   Common Stock
92,730
92,730
92,730
33,383
79,883
80,000
80,000
80,000
80,00080,00080,00079,88333,38392,73092,73092,730
   Retained Earnings 
-77,758
-67,161
-34,647
26,504
43,684
69,528
142,462
224,728
224,728142,46269,52843,68426,504-34,647-67,161-77,758
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
7,270
7,270
-34,647
0
53
106,822
179,756
262,022
262,022179,756106,822530-34,6477,2707,270



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2020-03-31)

Gross Profit (+$)
totalRevenue-
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense--
Operating Income-0
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense-0
 
Net Interest Income (+$)
Interest Income-
Interest Expense-0
Net Interest Income-0
 
Pretax Income (+$)
Operating Income-
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-0
EBIT - interestExpense = 195,273
31,960
0
Interest Expense0
Earnings Before Interest and Taxes (ebit)195,2730
Earnings Before Interest and Taxes (ebitda)-
 
After tax Income (+$)
Income Before Tax-
Tax Provision--
Net Income From Continuing Ops-0
Net Income-
Net Income Applicable To Common Shares108,967
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses287,929
Total Other Income/Expenses Net-0
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
VAMA.BSE
5 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VAMA.BSE.

VAMA.BSE Daily Candlestick Chart
UNISON.BSE
9 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of UNISON.BSE.

UNISON.BSE Daily Candlestick Chart
UNICHEMLAB.NSE
10 minutes ago

I found you a Death Cross on the daily chart of UNICHEMLAB.NSE.

UNICHEMLAB.NSE Daily Candlestick Chart
UMESLTD.NSE
10 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of UMESLTD.NSE.

UMESLTD.NSE Daily Candlestick Chart
TGBHOTELS.NSE
21 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TGBHOTELS.NSE.

TGBHOTELS.NSE Daily Candlestick Chart
TEXRAIL.BSE
21 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of TEXRAIL.BSE.

TEXRAIL.BSE Daily Candlestick Chart
TCMLMTD.BSE
23 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TCMLMTD.BSE.

TCMLMTD.BSE Daily Candlestick Chart
TARMAT.BSE
24 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TARMAT.BSE.

TARMAT.BSE Daily Candlestick Chart
TARMAT.NSE
25 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TARMAT.NSE.

TARMAT.NSE Daily Candlestick Chart
SYMPHONY.NSE
25 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SYMPHONY.NSE.

SYMPHONY.NSE Daily Candlestick Chart
SYMPHONY.BSE
25 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SYMPHONY.BSE.

SYMPHONY.BSE Daily Candlestick Chart
SWASTIVI.BSE
26 minutes ago

I found you a Golden Cross on the daily chart of SWASTIVI.BSE.

SWASTIVI.BSE Daily Candlestick Chart
SVCIND.BSE
26 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SVCIND.BSE.

SVCIND.BSE Daily Candlestick Chart
SUUMAYA.BSE
26 minutes ago

I found you a Three White Soldiers Candle Pattern on the daily chart of SUUMAYA.BSE.

SUUMAYA.BSE Daily Candlestick Chart
SUMIT.NSE
29 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SUMIT.NSE.

SUMIT.NSE Daily Candlestick Chart
SPCENET.NSE
32 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SPCENET.NSE.

SPCENET.NSE Daily Candlestick Chart
SMFIL.BSE
33 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SMFIL.BSE.

SMFIL.BSE Daily Candlestick Chart
SKMEGGPROD.NSE
34 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SKMEGGPROD.NSE.

SKMEGGPROD.NSE Daily Candlestick Chart
SIPTL.BSE
35 minutes ago

I found you a Death Cross on the daily chart of SIPTL.BSE.

SIPTL.BSE Daily Candlestick Chart
SIL.NSE
36 minutes ago

I found you a Evening Star Candle Pattern on the daily chart of SIL.NSE.

SIL.NSE Daily Candlestick Chart
SHRGLTR.BSE
36 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of SHRGLTR.BSE.

SHRGLTR.BSE Daily Candlestick Chart
SHRADHA.NSE
36 minutes ago

I found you a MACD Bullish Reversal Divergence on the daily chart of SHRADHA.NSE.

SHRADHA.NSE Daily Candlestick Chart
SHIVA.BSE
37 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHIVA.BSE.

SHIVA.BSE Daily Candlestick Chart